Rare diseases
Investigational molecules
Locations
Back to Hungary149 clinical trials in Gyor, Hungary across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
A Phase 3 Study of Sapablursen Compared with Placebo in Adults with Polycythemia Vera
HungaryStudy of AZD0486 plus rituximab versus standard chemotherapy drug combination in previously untreated follicular lymphoma patients
HungaryRinatabart Sesutecan plus bevacizumab vs standard care as maintenance for recurrent platinum‑sensitive ovarian cancer after second‑line chemotherapy
HungaryStudy of AZD0901 (sonesitatug vedotin) with capecitabine ± rilvegostomig in adults with advanced stomach or esophageal cancer (Claudin‑18.2‑positive, HER2‑negative)
HungaryA study of sacituzumab tirumotecan and bevacizumab in patients with newly diagnosed advanced ovarian cancer following first-line platinum-based chemotherapy
HungaryComparing sotorasib and pembrolizumab with chemotherapy for patients with advanced non-small cell lung cancer and a KRAS G12C mutation
HungaryA study to evaluate the safety and how the body processes the combination of ibuprofen and paracetamol in children and adolescents with acute pain
HungaryA study of palazestrant and ribociclib compared to letrozole and ribociclib for patients with advanced ER+ HER2- breast cancer
HungaryStudy of ziftomenib with drug combinations for adults with newly diagnosed acute myeloid leukemia with NPM1 or KMT2A genetic changes
HungaryA study comparing the effectiveness and safety of datopotamab deruxtecan and docetaxel in adults with advanced or metastatic non-squamous non-small cell lung cancer
HungaryStudy of oral cladribine compared to placebo for patients with generalized myasthenia gravis
HungaryStudy of Revumenib and Chemotherapy for Patients with Newly Diagnosed Acute Myeloid Leukemia with NPM1 Gene Mutation
HungaryThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on multiple cancer types, including breast, lung, and prostate cancer. Studies are evaluating novel combination therapies and immunotherapy approaches.
Research includes targeted therapies for hormone receptor-positive cancers and new treatment combinations for metastatic disease.
Research centered on treating chronic kidney disease and preventing cardiovascular events. Studies evaluating new therapeutic approaches for blood pressure management.
Focus on innovative combinations of medications to improve patient outcomes in cardiovascular conditions.
Clinical investigations examining treatments for autoimmune disorders and inflammatory conditions, including multiple sclerosis and ulcerative colitis.
Testing novel therapeutic approaches to modify immune response and reduce inflammation.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
